Trials / Completed
CompletedNCT04094818
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,441 (actual)
- Sponsor
- Inflammatix · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will analyze gene expression and other laboratory data from biological samples collected from participants with suspected respiratory, urinary, intra-abdominal, and/or skin \& soft tissue infections; or suspected sepsis of any cause.
Conditions
- Respiratory Tract Infections
- Urinary Tract Infections
- Intra-Abdominal Infections
- Skin and Soft Tissue Infection
- Suspected Meningitis/Encephalitis or Any Other Infection
- Sepsis
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | TriVerity | Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection and sputum/ BAL sample collection |
Timeline
- Start date
- 2020-02-28
- Primary completion
- 2024-08-06
- Completion
- 2024-09-30
- First posted
- 2019-09-19
- Last updated
- 2024-10-22
Locations
26 sites across 2 countries: United States, Greece
Source: ClinicalTrials.gov record NCT04094818. Inclusion in this directory is not an endorsement.